GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eternity Healthcare Inc (GREY:ETAH) » Definitions » Debt-to-EBITDA

Eternity Healthcare (Eternity Healthcare) Debt-to-EBITDA : -0.62 (As of Jul. 2018)


View and export this data going back to 2008. Start your Free Trial

What is Eternity Healthcare Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Eternity Healthcare's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jul. 2018 was $0.00 Mil. Eternity Healthcare's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jul. 2018 was $0.46 Mil. Eternity Healthcare's annualized EBITDA for the quarter that ended in Jul. 2018 was $-0.73 Mil. Eternity Healthcare's annualized Debt-to-EBITDA for the quarter that ended in Jul. 2018 was -0.62.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Eternity Healthcare's Debt-to-EBITDA or its related term are showing as below:

ETAH's Debt-to-EBITDA is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.255
* Ranked among companies with meaningful Debt-to-EBITDA only.

Eternity Healthcare Debt-to-EBITDA Historical Data

The historical data trend for Eternity Healthcare's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eternity Healthcare Debt-to-EBITDA Chart

Eternity Healthcare Annual Data
Trend Apr09 Apr10 Apr11 Apr12 Apr13 Apr14 Apr15 Apr16 Apr17 Apr18
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -1.74

Eternity Healthcare Quarterly Data
Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -1.05 -0.62

Competitive Comparison of Eternity Healthcare's Debt-to-EBITDA

For the Medical Devices subindustry, Eternity Healthcare's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eternity Healthcare's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eternity Healthcare's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Eternity Healthcare's Debt-to-EBITDA falls into.



Eternity Healthcare Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Eternity Healthcare's Debt-to-EBITDA for the fiscal year that ended in Apr. 2018 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.033 + 0.49) / -0.301
=-1.74

Eternity Healthcare's annualized Debt-to-EBITDA for the quarter that ended in Jul. 2018 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0.455) / -0.732
=-0.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jul. 2018) EBITDA data.


Eternity Healthcare  (GREY:ETAH) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Eternity Healthcare Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Eternity Healthcare's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Eternity Healthcare (Eternity Healthcare) Business Description

Traded in Other Exchanges
N/A
Address
18 Carnarvon Road, Flat/Room 1006 - 10th Floor, Hang Seng Tsim Sha Tsui Building, Tsim Sha TsuiI, Kowloon, Hong Kong, HKG
Eternity Healthcare Inc is a medical device company operating in the us. It focuses on manufacturing a needle-free injection system. The company emphasizes needle-free injection device technology for application in Diabetes, Pediatric Oncology, Multiple sclerosis, Multiple sclerosis, Anesthetics, Vaccine, Cardiovascular, and Migraine. The company adult stem cell storage is all located in North China, East China, and South China. The company targets market includes Guizhou, Yunan, Guangxi, Xinjiang, and Tibet.